Effect of Insulin Therapy by Ultrasonography in Wound Healing of Chronic Diabetic Patients
ConditionDiabetes Mellitus
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-65
SponsorMTI University
About this trial
The main aim of the study is to determine the effect of transdermal application of insulin therapy by phonophoresis in wound healing in diabetic patients the main question of the study: is insulin phonophoresis is effective in accelerating healing in patients with diabetes mellites? 40 patients will be randomly assigned to two groups group A will receive insulin phonophoresis plus hyper polarized laser therapy and standard wound cleaning and dressing three times weekly over four weeks.
Group B will receive hyper polarized laser therapy and standard wound cleaning and dressing three times weekly over four weeks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients will be included if they are free from any pathological condition like limb infection, local or proximate malignancy, and anti-coagulated patients.
Disqualifiers
None
Trial design
Design model
Parallel
Treatments tested in this trial
Insulin therapy phonophoresis
Other interventionInsulin therapy phonophoresis is the use of ultrasound to deliver drugs through patients skin, Insulin therapy will be used to determine its effect on wound healing in patients with chronic diabetes mellites because in addition to its systemic impact, numerous reports suggest that applying insulin topically causes localized effects. Many trials and case reports have been released reporting positive effects of topical insulin for many diseases such as dermatological compromises, ophthalmological diseases and others
Hyperpolarized light therapy and Standard wound cleaning and dressing.
Other interventionHyperpolarized light therapy safely accelerates wound healing by stimulating blood circulation, reducing inflammation and relieving muscle spasms.
Treatment groups
40 Participants
are divided into 2 treatment groupsGroup A: Group AExperimental treatment 2 interventions
Group B: Group BSham comparator 1 intervention
Trial outcomes
Primary outcomes
1
DMIST scale which is a valid and reliable scale for measuring depth, maceration, inflammation/infection, size, tissue type of the wound bed, type of wound edge, and tunneling/undermining.
Zero will be the minimum score and 98 was the maximum, with a greater number denoting a more severe injury and a zero signaling full recovery
Time frame
before first session and at the end of the treatment program (four weeks)Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: